In bladder cancer, tumor-suppressor genes such as RASSF1A, RUNX3, CDH13, and HOXA9 have been reported to undergo promoter hypermethylation, resulting in loss of tumor-inhibitory function (14, 15). Here, RUNX3 is linked to neoplasm.